Is there hope in the aftermath of a receding omicron wave? Plus more COVID news
Posted:
Updated:
World health officials are offering hope that the ebbing of the omicron wave could give way to a new, more manageable phase of the COVID-19 pandemic, even as they warn of difficult weeks ahead and the possibility of another, more dangerous variant arising.
In the U.S., cases have crested and are dropping rapidly, following a pattern seen in Britain and South Africa, with researchers projecting a period of low spread in many countries by the end of March. Though U.S. deaths — now at 2,000 each day — are still rising, new hospital admissions have started to fall, and a drop in deaths is expected to follow.
The encouraging trends after two years of coronavirus misery have brought a noticeably hopeful tone from health experts. Rosy predictions have crumbled before, but this time they are backed by what could be called omicron’s silver lining: The highly contagious variant will leave behind extremely high levels of immunity.
COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they are unlikely to work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health regulators said Monday.
The Food and Drug Administration said it was revoking emergency authorization for both drugs, which were purchased by the federal government and given to millions of Americans with COVID-19. If the drugs prove effective against future variants, the FDA said it could reauthorize their use.
A cluster of COVID-19 cases in Beijing has prompted authorities to test millions and impose new measures two weeks ahead of the opening of the Winter Olympics, even as the city of Xi’an in north-central China lifted on Monday a monthlong lockdown that had isolated its 13 million residents.
Officials in Beijing said they would conduct a second round of mass testing of the Fengtai district’s 2 million residents, where the majority of the capital’s 40 coronavirus cases since Jan. 15 have been found. That came a day after authorities announced that anyone who buys or who has bought fever, cough or certain other medicines in the past two weeks would be required to take a COVID-19 test within 72 hours.
-
Edward A. "Doc" Rogers/Library of Congress via AP, File
How it started: Unclear, but probably not in Spain. It was a particularly deadly strain of H1N1 influenza and first took root in the U.S. in Kansas.
The disease was so virulent and killed so many young people that if you heard “‘This is just ordinary influenza by another name,’ you knew that was a lie,” said John Barry, the author of “The Great Influenza.”
If the flu did hit your town, it hit hard: A young person could wake up in the morning feeling well and be dead 24 hours later. Half the people who died of the flu in 1918 were in their 20s and 30s.
“It was a spooky time,” said Georges Benjamin, executive director of the American Public Health Association.
So how did we, as a species, beat the Spanish flu? We didn’t. We survived it. A third of the world’s population was believed to have contracted the Spanish flu during that pandemic, and it had a case-fatality rate of as high as 10-20% globally and 2.5% in the United States. Roughly 675,000 people in America died out of a population of 103.2 million, a number recently surpassed by COVID-19 victims of a 2020 U.S. population of 329.5 million. Flu vaccines wouldn’t be developed until the 1930s and wouldn’t become widely available for another decade.
Ultimately, the virus went through a process called attenuation. Basically, it got less bad. We still have descendent strains of the Spanish flu floating around today. It’s endemic, not a pandemic.
As a society, we accept a certain amount of death from known diseases. The normal seasonal flu usually kills less than 0.1% of people who contract it. Deaths have been between 12,000 and 52,000 people in the U.S. annually for the past decade.
The regular seasonal flu is both less contagious and less deadly than COVID-19. That people were washing hands, working from home and socially distancing in the winter 2020 flu season likely contributed to the fact that it was a comparably light flu season.
How it ended: Endemic
Edward A. "Doc" Rogers/Library of Congress via AP, FileHow it started: Unclear, but probably not in Spain. It was a particularly deadly strain of H1N1 influenza and first took root in the U.S. in Kansas.
The disease was so virulent and killed so many young people that if you heard “‘This is just ordinary influenza by another name,’ you knew that was a lie,” said John Barry, the author of “The Great Influenza.”
If the flu did hit your town, it hit hard: A young person could wake up in the morning feeling well and be dead 24 hours later. Half the people who died of the flu in 1918 were in their 20s and 30s.
“It was a spooky time,” said Georges Benjamin, executive director of the American Public Health Association.
So how did we, as a species, beat the Spanish flu? We didn’t. We survived it. A third of the world’s population was believed to have contracted the Spanish flu during that pandemic, and it had a case-fatality rate of as high as 10-20% globally and 2.5% in the United States. Roughly 675,000 people in America died out of a population of 103.2 million, a number recently surpassed by COVID-19 victims of a 2020 U.S. population of 329.5 million. Flu vaccines wouldn’t be developed until the 1930s and wouldn’t become widely available for another decade.
Ultimately, the virus went through a process called attenuation. Basically, it got less bad. We still have descendent strains of the Spanish flu floating around today. It’s endemic, not a pandemic.
As a society, we accept a certain amount of death from known diseases. The normal seasonal flu usually kills less than 0.1% of people who contract it. Deaths have been between 12,000 and 52,000 people in the U.S. annually for the past decade.
The regular seasonal flu is both less contagious and less deadly than COVID-19. That people were washing hands, working from home and socially distancing in the winter 2020 flu season likely contributed to the fact that it was a comparably light flu season.
How it ended: Endemic
-
AP Photo, File
How it started: The first documented polio epidemic in the United States was in 1894. Outbreaks occurred throughout the first half of the 20th century, primarily killing children and leaving many more paralyzed.
Polio reached pandemic levels by the 1940s. There were more than 600,000 cases of polio in the United States in the 20th century, and nearly 60,000 deaths — a case fatality rate of 9.8%. In 1952 alone, there were 57,628 reported cases of polio resulting in 3,145 deaths.
“Polio was every mother’s scourge,” Benjamin said. “People were afraid to death of polio.”
Polio was highly contagious: In a household with an infected adult or child, 90% to 100% of susceptible people would develop evidence in their blood of also having been infected. Polio is not spread through the air — transmission occurs from oral-oral infection (say, sharing a drinking glass), or by “what’s nicely called hand-fecal,” Paula Cannon, a virology professor at the University of Southern California Keck School of Medicine, told me. “People poop it out, and people get it on their hands and they make you a sandwich.”
Polio, like COVID-19, could have devastating long-term effects even if you survived the initial infection. President Franklin Roosevelt was among the thousands of people who lived with permanent paralysis from polio. Others spent weeks, years, or the rest of their lives in iron lungs.
Precautions were taken during the polio pandemic. Schools and public pools closed. Then, in 1955, a miracle: a vaccine.
A two-dose course of the polio vaccine proved to be about 90% effective — similar to the effectiveness of our current COVID-19 vaccines. Vaccine technology was still relatively new, and the polio vaccine was not without side effects. A small number of people who got that vaccine got polio from it. Another subset of recipients developed Guillain-Barre syndrome, a noncontagious autoimmune disorder that can cause paralysis or nerve damage. A botched batch killed some of the people who received it.
Benjamin said the polio vaccine campaign became a moment of national unity: “Jonas Salk and the folks that solved the polio problem were national heroes.”
By 1979, polio was eradicated in the United States.
How it ended: Vaccination
AP Photo, FileHow it started: The first documented polio epidemic in the United States was in 1894. Outbreaks occurred throughout the first half of the 20th century, primarily killing children and leaving many more paralyzed.
Polio reached pandemic levels by the 1940s. There were more than 600,000 cases of polio in the United States in the 20th century, and nearly 60,000 deaths — a case fatality rate of 9.8%. In 1952 alone, there were 57,628 reported cases of polio resulting in 3,145 deaths.
“Polio was every mother’s scourge,” Benjamin said. “People were afraid to death of polio.”
Polio was highly contagious: In a household with an infected adult or child, 90% to 100% of susceptible people would develop evidence in their blood of also having been infected. Polio is not spread through the air — transmission occurs from oral-oral infection (say, sharing a drinking glass), or by “what’s nicely called hand-fecal,” Paula Cannon, a virology professor at the University of Southern California Keck School of Medicine, told me. “People poop it out, and people get it on their hands and they make you a sandwich.”
Polio, like COVID-19, could have devastating long-term effects even if you survived the initial infection. President Franklin Roosevelt was among the thousands of people who lived with permanent paralysis from polio. Others spent weeks, years, or the rest of their lives in iron lungs.
Precautions were taken during the polio pandemic. Schools and public pools closed. Then, in 1955, a miracle: a vaccine.
A two-dose course of the polio vaccine proved to be about 90% effective — similar to the effectiveness of our current COVID-19 vaccines. Vaccine technology was still relatively new, and the polio vaccine was not without side effects. A small number of people who got that vaccine got polio from it. Another subset of recipients developed Guillain-Barre syndrome, a noncontagious autoimmune disorder that can cause paralysis or nerve damage. A botched batch killed some of the people who received it.
Benjamin said the polio vaccine campaign became a moment of national unity: “Jonas Salk and the folks that solved the polio problem were national heroes.”
By 1979, polio was eradicated in the United States.
How it ended: Vaccination
-
AP Photo/Frank Franklin II
How it started: The disease had been observed in the Eastern Hemisphere dating to as early as 1157 B.C., and European colonizers first brought smallpox to North America’s previously unexposed Native population in the early 1500s. Globally, smallpox is estimated to have killed more than 300 million people just in the 20th century. The case fatality rate of variola major, which caused the majority of smallpox infections, is around 30%.
Outbreaks continued in North America through the centuries after it arrived here. We fought back by trying to infect people with a weakened version of it, long before vaccines existed. An enslaved man named Onesimus is believed to have introduced the concept of smallpox inoculation to North America in 1721 when he told slave owner Cotton Mather that he had undergone it in West Africa. Mather tried to convince doctors to consider inoculating residents during that outbreak, to limited success. One doctor who inoculated 287 patients reported only 2% of them died of smallpox, compared with a 14.8% death rate among the general population.
In 1777, George Washington ordered troops who had not already had the disease to undergo a version of inoculation in which pus from a smallpox sore was introduced into an open cut. Most people who were inoculated developed a mild case of smallpox, then developed natural immunity. Some died, though at a far lower rate compared with other ways of contracting the disease.
Edward Jenner first demonstrated the effectiveness of his newly created smallpox vaccine in England in 1796. Vaccination spread throughout the world.
But while early vaccines reduced smallpox’s power, it still existed: An outbreak hit New York City in 1947. It demonstrated that the vaccines were not 100% effective in everyone forever: 47-year-old Eugene Le Bar, the first fatality, had a smallpox vaccine scar. Israel Weinstein, the city’s health commissioner, held a news conference urging all New Yorkers to get vaccinated against smallpox, whether for the first time or what we would now call a “booster shot.”
The mayor and President Harry Truman got vaccinated on camera. In less than one month, 6.35 million New Yorkers were vaccinated, in a city of 7.8 million. The final toll of the New York outbreak: 12 cases of smallpox, resulting in 2 deaths.
Our country’s final outbreak affected eight people in the Rio Grande Valley in 1949. In 1959, the World Health Organization announced a plan to eradicate smallpox globally with vaccinations. The disease was declared eradicated in 1980.
How it ended: Vaccination
AP Photo/Frank Franklin IIHow it started: The disease had been observed in the Eastern Hemisphere dating to as early as 1157 B.C., and European colonizers first brought smallpox to North America’s previously unexposed Native population in the early 1500s. Globally, smallpox is estimated to have killed more than 300 million people just in the 20th century. The case fatality rate of variola major, which caused the majority of smallpox infections, is around 30%.
Outbreaks continued in North America through the centuries after it arrived here. We fought back by trying to infect people with a weakened version of it, long before vaccines existed. An enslaved man named Onesimus is believed to have introduced the concept of smallpox inoculation to North America in 1721 when he told slave owner Cotton Mather that he had undergone it in West Africa. Mather tried to convince doctors to consider inoculating residents during that outbreak, to limited success. One doctor who inoculated 287 patients reported only 2% of them died of smallpox, compared with a 14.8% death rate among the general population.
In 1777, George Washington ordered troops who had not already had the disease to undergo a version of inoculation in which pus from a smallpox sore was introduced into an open cut. Most people who were inoculated developed a mild case of smallpox, then developed natural immunity. Some died, though at a far lower rate compared with other ways of contracting the disease.
Edward Jenner first demonstrated the effectiveness of his newly created smallpox vaccine in England in 1796. Vaccination spread throughout the world.
But while early vaccines reduced smallpox’s power, it still existed: An outbreak hit New York City in 1947. It demonstrated that the vaccines were not 100% effective in everyone forever: 47-year-old Eugene Le Bar, the first fatality, had a smallpox vaccine scar. Israel Weinstein, the city’s health commissioner, held a news conference urging all New Yorkers to get vaccinated against smallpox, whether for the first time or what we would now call a “booster shot.”
The mayor and President Harry Truman got vaccinated on camera. In less than one month, 6.35 million New Yorkers were vaccinated, in a city of 7.8 million. The final toll of the New York outbreak: 12 cases of smallpox, resulting in 2 deaths.
Our country’s final outbreak affected eight people in the Rio Grande Valley in 1949. In 1959, the World Health Organization announced a plan to eradicate smallpox globally with vaccinations. The disease was declared eradicated in 1980.
How it ended: Vaccination
-
(AP Photo/Bebeto Matthews
How it started: In 1981, the CDC announced the first cases of what we would later call AIDS.
Roughly half of Americans who contracted HIV in the early 1980s died of an HIV/AIDS-related condition within two years. Deaths from HIV peaked in the 1990s, with roughly 50,000 in 1995, and have decreased steadily since then: As of 2019, roughly 1.2 million Americans are HIV-positive; there were 5,044 deaths attributed to HIV that year.
Unlike COVID-19, which was quickly identified as a respiratory disease, HIV spread for years before scientists knew for sure how it was transmitted.
Today, we know how to prevent the spread of HIV, and treatments for it have progressed to the point where early intervention can make the virus completely undetectable.
Around 700,000 people in the U.S. have died of HIV-related illnesses in the 40 years since the disease appeared.
How it ended: Endemic
(AP Photo/Bebeto MatthewsHow it started: In 1981, the CDC announced the first cases of what we would later call AIDS.
Roughly half of Americans who contracted HIV in the early 1980s died of an HIV/AIDS-related condition within two years. Deaths from HIV peaked in the 1990s, with roughly 50,000 in 1995, and have decreased steadily since then: As of 2019, roughly 1.2 million Americans are HIV-positive; there were 5,044 deaths attributed to HIV that year.
Unlike COVID-19, which was quickly identified as a respiratory disease, HIV spread for years before scientists knew for sure how it was transmitted.
Today, we know how to prevent the spread of HIV, and treatments for it have progressed to the point where early intervention can make the virus completely undetectable.
Around 700,000 people in the U.S. have died of HIV-related illnesses in the 40 years since the disease appeared.
How it ended: Endemic
-
AP Photo/Eugene Hoshiko
How it started: SARS first appeared in China in 2002 before making its way to the United States and 28 other countries.
Severe acute respiratory syndrome — quickly shortened to SARS in headlines and news coverage — is caused by a coronavirus named SARS-CoV, or SARS-associated coronavirus. COVID-19 is caused by a virus so similar that it’s called SARS-CoV-2.
Globally, more than 8,000 people contracted SARS during the outbreak, and 916 died. One hundred fifteen cases of SARS were suspected in the United States; only eight people had laboratory-confirmed cases of the disease, and none of them died. Like COVID-19, fatality rates from SARS were very low for young people — less than 1% for people under 25 — up to a more than 50% rate for people over 65. Overall, the case fatality rate was 11%.
Public anxiety was widespread, including in areas unaffected by SARS.
SARS and COVID-19 have a lot in common. But the diseases weren’t exactly the same, said Benjamin, who worked for the CDC during the SARS epidemic.
Conversely to COVID-19, he said, the response to SARS was robust and immediate. The WHO issued a global alert about an unknown and severe form of pneumonia in Asia on March 12, 2003. The CDC activated its Emergency Operations Center by March 14, and issued an alert for travelers entering the U.S. from Hong Kong and parts of China the next day. Pandemic planning and guidance went into effect by the end of that month.
In the case of SARS, the disease stopped spreading before a vaccine or cure could be created.
How it ended: Died out after being controlled by public health measures
AP Photo/Eugene HoshikoHow it started: SARS first appeared in China in 2002 before making its way to the United States and 28 other countries.
Severe acute respiratory syndrome — quickly shortened to SARS in headlines and news coverage — is caused by a coronavirus named SARS-CoV, or SARS-associated coronavirus. COVID-19 is caused by a virus so similar that it’s called SARS-CoV-2.
Globally, more than 8,000 people contracted SARS during the outbreak, and 916 died. One hundred fifteen cases of SARS were suspected in the United States; only eight people had laboratory-confirmed cases of the disease, and none of them died. Like COVID-19, fatality rates from SARS were very low for young people — less than 1% for people under 25 — up to a more than 50% rate for people over 65. Overall, the case fatality rate was 11%.
Public anxiety was widespread, including in areas unaffected by SARS.
SARS and COVID-19 have a lot in common. But the diseases weren’t exactly the same, said Benjamin, who worked for the CDC during the SARS epidemic.
Conversely to COVID-19, he said, the response to SARS was robust and immediate. The WHO issued a global alert about an unknown and severe form of pneumonia in Asia on March 12, 2003. The CDC activated its Emergency Operations Center by March 14, and issued an alert for travelers entering the U.S. from Hong Kong and parts of China the next day. Pandemic planning and guidance went into effect by the end of that month.
In the case of SARS, the disease stopped spreading before a vaccine or cure could be created.
How it ended: Died out after being controlled by public health measures
-
-
AP Photo/Paul Sancya
How it started: Both the Spanish flu and swine flu were caused by the same type of virus: influenza A H1N1.
Ultimately, according to the CDC, there were about 60.8 million cases of swine flu in the U.S. from April 2009 to April 2010, with 274,304 hospitalizations and 12,469 deaths. So there were millions more cases of swine flu than there were of COVID-19 in the same time period, but a fraction of the fatalities. Eighty percent of swine flu deaths were in people younger than 65.
It was first detected in California on April 15, 2009, and the CDC and the Obama administration declared public health emergencies before the end of that month. In the same month cases were first detected, the CDC started identifying the virus strain for a potential vaccine. The first flu shots with H1N1 protections went into arms in October 2009. WHO declared the swine flu pandemic over in August 2010. But like Spanish flu, swine flu never completely went away.
How it ended: Endemic
AP Photo/Paul SancyaHow it started: Both the Spanish flu and swine flu were caused by the same type of virus: influenza A H1N1.
Ultimately, according to the CDC, there were about 60.8 million cases of swine flu in the U.S. from April 2009 to April 2010, with 274,304 hospitalizations and 12,469 deaths. So there were millions more cases of swine flu than there were of COVID-19 in the same time period, but a fraction of the fatalities. Eighty percent of swine flu deaths were in people younger than 65.
It was first detected in California on April 15, 2009, and the CDC and the Obama administration declared public health emergencies before the end of that month. In the same month cases were first detected, the CDC started identifying the virus strain for a potential vaccine. The first flu shots with H1N1 protections went into arms in October 2009. WHO declared the swine flu pandemic over in August 2010. But like Spanish flu, swine flu never completely went away.
How it ended: Endemic
-
AP Photo/Jerome Delay, File
How it started: From 2014 to 2016, 28,616 people in West Africa had Ebola, and 11,310 died — a 39.5% case fatality rate. Despite widespread fears about it spreading here, only two people contracted Ebola on U.S. soil, and neither died.
So how did we escape Ebola? Unlike COVID-19, Ebola isn’t transmitted in the air, and there’s no asymptomatic spread. It spreads through the bodily fluids of people actively experiencing symptoms, either directly or through bedding and other objects they’ve touched. If you haven’t been within 3 feet of a person with Ebola, you have almost no risk of getting it.
Part of the problem in Africa, Benjamin said, was that families traditionally washed the bodies of the deceased, exposing themselves to infected fluids. Once adequate equipment was delivered to affected areas and precautions were taken by health care workers and families of the victims, the disease could be controlled.
While this particular outbreak ended in 2016, it’s very possible we will see another Ebola event in the future. An Ebola vaccine was approved by the FDA in 2019.
How it ended: Subsided after being controlled by public health measures
AP Photo/Jerome Delay, FileHow it started: From 2014 to 2016, 28,616 people in West Africa had Ebola, and 11,310 died — a 39.5% case fatality rate. Despite widespread fears about it spreading here, only two people contracted Ebola on U.S. soil, and neither died.
So how did we escape Ebola? Unlike COVID-19, Ebola isn’t transmitted in the air, and there’s no asymptomatic spread. It spreads through the bodily fluids of people actively experiencing symptoms, either directly or through bedding and other objects they’ve touched. If you haven’t been within 3 feet of a person with Ebola, you have almost no risk of getting it.
Part of the problem in Africa, Benjamin said, was that families traditionally washed the bodies of the deceased, exposing themselves to infected fluids. Once adequate equipment was delivered to affected areas and precautions were taken by health care workers and families of the victims, the disease could be controlled.
While this particular outbreak ended in 2016, it’s very possible we will see another Ebola event in the future. An Ebola vaccine was approved by the FDA in 2019.
How it ended: Subsided after being controlled by public health measures
-
AP Photo/Jae C. Hong
The most likely outcome at this point is that COVID-19 is here to stay, Benjamin said: “I think most people now think that it will be endemic for a while.”
COVID-19 has a lot going for it, as far as viruses go: Unlike Ebola and SARS, it can be spread by people who don’t realize they have it. Unlike smallpox, it can jump species, infecting animals and then potentially reinfecting us. Unlike polio, one person can unwittingly spread it to a room full of people, and not enough people are willing to get vaccinated at once to stop it in its tracks.
So what happens next? In some populations, enough people will get vaccinated to achieve something like herd immunity. In others, it will burn through the population until everyone’s had it, and either achieves naturally gained immunity (which confers less long-term protection than vaccination) or dies. People still die from influenza and HIV in the United States; a disease becoming endemic isn’t exactly a happy ending.
How it ends: A combination of vaccine- and naturally gained immunity, attenuation, availability of rapid testing, and improvements in treatment for active cases could turn it into what skeptics called it to begin with: a bad cold or flu.
AP Photo/Jae C. HongThe most likely outcome at this point is that COVID-19 is here to stay, Benjamin said: “I think most people now think that it will be endemic for a while.”
COVID-19 has a lot going for it, as far as viruses go: Unlike Ebola and SARS, it can be spread by people who don’t realize they have it. Unlike smallpox, it can jump species, infecting animals and then potentially reinfecting us. Unlike polio, one person can unwittingly spread it to a room full of people, and not enough people are willing to get vaccinated at once to stop it in its tracks.
So what happens next? In some populations, enough people will get vaccinated to achieve something like herd immunity. In others, it will burn through the population until everyone’s had it, and either achieves naturally gained immunity (which confers less long-term protection than vaccination) or dies. People still die from influenza and HIV in the United States; a disease becoming endemic isn’t exactly a happy ending.
How it ends: A combination of vaccine- and naturally gained immunity, attenuation, availability of rapid testing, and improvements in treatment for active cases could turn it into what skeptics called it to begin with: a bad cold or flu.
